Sector ratings Laboratorios Farmaceuticos Rovi, S.A. OTC Markets
Stocks
LABFF
ES0157261019
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.86 USD | -27.31% |
|
-.--% | - |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,067B | A | |||||||
| 635B | BBB | |||||||
| 458B | AA | - | ||||||
| 347B | AA | |||||||
| 295B | AAA | |||||||
| 262B | A | |||||||
| 216B | A | |||||||
| 203B | A | |||||||
| 161B | AA | |||||||
| 140B | A | |||||||
| 127B | A | |||||||
| 121B | AA | |||||||
| 104B | AA | |||||||
| 102B | AA | |||||||
| 74.54B | AA | |||||||
| 63.66B | - | - | - | - | - | - | - | |
| 55.09B | AA | |||||||
| 52.08B | AA | |||||||
| 51.52B | AA | |||||||
| Average | 238.65B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
